Effects of 4-(3-indolyl-alkyl)piperidine derivatives on uptake and release of noradrenaline, dopamine and 5-hydroxytryptamine in rat brain synaptosomes, rat heart and human blood platelets.
D000818:Animals; D000929:Antidepressive Agents, Tricyclic / Q000494:pharmacology; D001692:Biological Transport; D001792:Blood Platelets / Q000187:drug effects / Q000378:metabolism*; D001921:Brain / Q000187:drug effects / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism*; D005260:Female; D006321:Heart / Q000187:drug effects; D006801:Humans; D007211:Indoles / Q000494:pharmacology; D007490:Iproniazid / Q000494:pharmacology; D007700:Kinetics; D009206:Myocardium / Q000378:metabolism*; D009638:Norepinephrine / Q000378:metabolism*; D010880:Piperidines / Q000494:pharmacology*; D051381:Rats; D012110:Reserpine / Q000494:pharmacology; D012701:Serotonin / Q000378:metabolism*; D013574:Synaptosomes / Q000187:drug effects / Q000378:metabolism*
D000929:Antidepressive Agents, Tricyclic; D007211:Indoles; D010880:Piperidines; D012701:Serotonin; D012110:Reserpine; D007490:Iproniazid; D004298:Dopamine; D009638:Norepinephrine